-
Exclusive: DelMar Pharma CEO Sheds Light On Glioblastoma, And How Its Drug Could Help Sen. John McCain
Friday, July 21, 2017 - 10:09am | 915Read More...Glioblastoma is a rare type of brain cancer thrust into the spotlight after it was reported Sen. John McCain has been diagnosed with the very aggressive disease. Glioblastoma affects 15,000–17,000 new patients in the United States every year, and treatment options haven’t changed much...
-
Exclusive: Interview With DelMar Pharmaceutical CEO Jeffrey Bacha
Saturday, October 8, 2016 - 5:34pm | 505Read More...Glioblastoma is a rare form of brain cancer that sees less than 200,000 new cases in the United States annually. Vancouver-based Biotech company DelMar Pharmaceuticals Inc (NASDAQ: DMPI) is making significant strides in fighting this rare disease. With maximum treatment, glioblastoma remains a...



